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Abstract. The effect of guanosine 3', 5'-triphosphate (GTP) on the hemoglobin structure was studied by 
UV-visible, fluorescence and circular dichroism (CD) spectroscopies, and cyclic voltammetry.  
UV-visible absorption spectra showed an increase in absorbance in the regions of 420 nm and 280 nm.  
Fluorescence spectra showed that the Trp fluorescence intensity increased upon excitation at 280 nm, 
when guanosine 3', 5'-triphosphate concentration was increased in hemoglobin solution. Along with the 
increased fluorescence intensity, a slightly shift of λmax was also observed toward the higher wavelengths. 
CD spectral analysis demonstrated a significant decrease in negative ellipsity in the region of 205–235 
nm. After adding guanosine 3', 5'-triphosphate to the hemoglobin solution α-helix structure decreases by 
20 % while β-sheet conformation increases by 9 %. The effects of GTP on hemoglobin resulted in a  
61 mV shift in the cathodic and 40 mV for anodic peak of hemoglobin in the CD. Our data showed the 
change of secondary and tertiary structure of hemoglobin in the presence of guanosine 3', 5'-triphosphate.  
(doi: 10.5562/cca1955) 
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INTRODUCTION 
Hemoglobin is a hetero-tetramer, consisting of two  
α-subunits and two β-subunits (a "dimer of dimers" 
[ß (2) : α (2)]). Each polypeptide chain contains a  
prosthetic heme group, which cooperatively binds and 
releases oxygen.1–3 Hemoglobin undergoes major  
tertiary and quaternary conformational changes as it 
equilibrates between a low-affinity deoxy T-state and a 
high-affinity oxy R-state.4 Organic phosphates and 
some heterotrophic effectors, such as protons, anions 
and carbon dioxide, although bound spatially at the 
remote sites, could affect the oxygenation process and 
have been shown to affect the oxidation process  
as well.1,5–7 Some organic phosphates, such as  
diphosphoglycerate (DPG), bind with a site of hemo-
globin, in 1:1 stoichimetry, which is located at the en-
trance of the cavity between two β-subunits. These 
subunits contribute positively charged residues to com-
plement the negatively charged DPG phosphate groups, 
namely Val1, His2 and Lys82 of both the β-chains.8 
Moreover, inositol hexaphosphate (IHP) and DPG can 
bind to the hemoglobin at the same site.8 The allosteric 
function of these materials leads to its binding with the 
hemoglobin and changing the R-like state of hemoglo-
bin to T-like state, and decreasing the oxygen affinity of  
hemoglobin.1,8 It is known that GTP is very important 
factor in the erythroid differentiation and stimulates it 
for the synthesis of hemoglobin and other proteins.9 
GTP has the main role in activating or deactivating 
some proteins in the cell, such as kinases and  
G-proteins.10 Since, its important roles in erythroid 
differenciation, where hemoglobin is generated,  
investigations about the effects of this material on the 
structural changes of hemoglobin and its affinity to 
oxygen are very important. Tamburrini et al. have  
reported that the affinity of hemoglobin, for oxygen, 
was reduced dramatically in the present of GTP.11 
However, there are still unanswered questions like: how 
GTP affects the hemoglobin structure?  
Here we report the investigation of the structural 
changes of hemoglobin, related to the binding of GTP, 
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Human adult hemoglobin (HbA), KNO3, GTP, 
3-(N-morpholino)propanesulfonic acid (MOPS) (99 %) 
and KI were purchased from Sigma. Double distilled 
water was used in all the experiments. Stock solutions 
were stored at 4 C.  
 
UV-Visible Spectroscopy 
The UV-Visible absorption spectra were measured with 
a UV60A spectrophotometer (Shimadzu, Japan), using a 
1 cm quartz cuvette. Spectral changes of 1.5 µM  
hemoglobin were monitored after adding different con-
centration of GTP by recording the UV-visible absorp-
tion (250−500 nm), (0.1 M MOPS buffer; pH 7.0).  
 
Fluorescence Experiments 
A fluorescence spectrophotometer (Model MPF-4, Hita-
chi, Japan), equipped with a temperature controller bath 
(Model NTB-211), was used for all of the fluorescence 
experiments. The excitation wavelength, adjusted at 280 
nm during the whole experiment, was specific for the 
excitation of the tryptophan residues in the protein 
structure. The emission spectra were recorded between 
the wavelengths of 300 to 400 nm at the band-width of 
10 nm. Hemoglobin sample was provided at the concen-
tration of 1.5 µM in a 0.1 M MOPS buffer (pH 7.0). 
 
CD Spectroscopy  
CD spectra were collected, between 190 and 260 nm, 
with an Aviv CD spectrometer at 25 °C. The CD assay 
was performed using a 1 mm path length cell with the 
protein concentration of 0.2 µM in the 0.1 M MOPS 
buffer (pH 7.0) with different concentration of GTP. 
The molar elasticity values were collected from the CD 
spectra. CDNN program was used to calculate the  




Electrochemical measurements were carried out with a 
Potentiostat/Galvanostat (Model 263A, EG&G, USA) 
using a single-compartment voltammetric cell, equipped 
with a platinum rod auxiliary electrode, an Ag/AgCl 
reference electrode (Metrohm) and an iodide modified 
silver working electrode with a disk diameter of 1 mm 
(Azar Electrode Co; Iran). Iodide modified working 
electrode was prepared by the method stated by some 
previous workers.13–15 First, the silver electrode was 
mechanically polished twice with alumina (particle sizes 
10 and 0.06 µm, respectively) to a mirror finish. Then, 
the adsorbed species were further removed by etching 
the electrode in 10 % HNO3 solution for 1 minute.  
Finally, the electrode was thoroughly washed with dou-
ble distilled water followed by treating it in an  
ultrasonic bath for about 3 minutes. After this  
pre-treatment, the substrate silver electrode was  
immerse in a 0.1 mol/L KI solution for 5 minutes and 
then thoroughly rinsed with double distilled water to 
remove any physic-absorbed material. The iodide  
modified silver electrode was then ready for use. All the 
solutions were de-aerated by bubbling with high purity 
nitrogen for at least 30 minutes before the experiments. 
 
RESULTS AND DISCUSSION 
UV-visible absorption spectra were recorded for the 
conformational changes of hemoglobin (1.5 µM), in the 
solution, when GTP was added at different concentra-
tions. As shown in Figure 1, an increase in absorbance 
was seen in the region of 420 nm (due to the Soret  
absorption by the heme system) and 280 nm (due to 
tryptophan absorption).16,17 Naturally, the tryptophan  
residue (hydrophobic amino acid) of hemoglobin is 
confined inside the protein molecule.16 Increase of  
absorption in the region of 280 nm shows that interac-
tion of GTP, with hemoglobin, caused the tryptophan 
residues to migrate towards the protein surface and 
increased surface accessibility of tryptophan.16–18 While, 
the increased absorption at 420 nm can be because of 
the same effect of GTP on the surface accessibility of 
heme group, as a result of conformational changes in 
hemoglobin structure during the interaction of GTP with 
hemoglobin.16–18 In fact, the interaction between protein 
and GTP caused the changes in protein structure and 
increased the absorption of Trp residues/heme groups.  
Figure 1. The effect of GTP concentration (0, 75, 150, 225
µM) on UV-visible spectrum of hemoglobin (1.5 µM). 
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Figure 2 shows the gradual increase of the  
intrinsic tryptophan fluorescence during the addition of 
GTP in the solution containing 1.5 µM hemoglobin. 
Excited at 280 nm, the Trp intensity increased with 
increase in GTP concentration. Along with the increased 
fluorescence intensity, a slightly shift of λmax was also 
observed toward the higher wavelengths. So, our data 
showed a close correlation between the intrinsic fluo-
rescence intensity of tryptophan and the results obtained 
by the UV-visible spectrophotometry. With the increase 
of GTP concentration to hemoglobin solution, an in-
crease of fluorescence emission was observed, which 
can also be the outcome of more contact of tryptophan 
residues to the environment.17–20 In general, a Trp in a 
hydrophobic environment exhibits maximum emission 
at lower wavelengths as compared to a hydrophilic- or 
exposed-environment.17–20 As it is shown in Figure 2, 
with the increase of GTP as well as the Trp fluorescence 
intensity, λmax was slightly shifted toward the higher 
wavelengths (red shift). This observation shows that 
when the protein interacted with the GTP, Trp residues 
were exposed to more hydrophilic environment, which 
also shows the structural change and unfolding of the  
protein. 
Figure 3 shows GTP-induced conformational 
changes of hemoglobin by CD spectral analysis. The 
CD spectra, at far UV region of GTP-hemoglobin, are 
very different from the spectrum of hemoglobin. A 
significant decrease in negative ellipsity was seen in the 
region of 205–235 nm, which shows a significant 
change in the secondary structure of hemoglobin during 
its interaction with GTP.16–20 After adding 30 µM GTP 
to 0.2 µM hemoglobin solution, the α-helix structure of 
the protein decreased approximately 20 %, while  
β-sheet conformation increased approximately 9 %. 
These results show some changes in the secondary 
structure of hemoglobin after the interaction with GTP. 
Figure 4 shows the cyclic voltammetric effects of 
GTP, on the hemoglobin (30 µM) in solution, by using 
iodide-modified silver electrode. Inset of Figure 4 
shows the relationship between E°' and [GTP]. The 
cathodic peak of hemoglobin shifts 61 mV and anodic 
peak shifts 40 mV to positive direction with the GTP 
concentration ranging from 0 to 4.5 mM. It almost 
makes no cyclic voltammogram (CV) changes for he-
moglobin at the GTP concentrations above 4.5 mM. CV 
studies also show no shift in both the cathodic and anod-
ic peaks in the presence of 4 mM guanosine (data not 
shown). These results indicate that only the phosphate 
part of GTP can interact with hemoglobin. Positive shift 
of cathodic and anodic peaks of hemoglobin by GTP 
interaction means the easier redox behavior of hemo-
globin in the presence GTP.21 It seems that GTP can 
change the structure and cause the unfolding of hemo-
globin. While, the heme group would change its posi-
tion from the inside to the surface of hemoglobin.21–23  
It seems that GTP can bind and change the secondary 
and tertiary structures of hemoglobin. We showed that 
reason of the decreased affinity of hemoglobin for oxy-
gen, as stated by Tamburrini et al.,11 may be because of 
the changed secondary and tertiary structures of hemo-
globin. Our data suggest that GTP acts as a regulator of 
hemoglobin’s affinity for oxygen by structural changes 
in the protein. 
Figure 2. The effect of GTP concentration (0, 75, 150, 225,
300 µM) on florescence spectrum of hemoglobin (1.5 M).
(λmax = 280 nm). 
Figure 3. The effect of GTP concentration (0, 10, 20, 30 µM)
on CD spectrum of hemoglobin (0.2 µM). 
Figure 4. Cyclic voltammograms of hemoglobin (30 µM) in
the presence of a) 0, b) 1.5, c) 3.0, d) 4.5 and e) 6.0 mM of
GTP, respectively. Inset shows the plot of [GTP] vs. E°’. 
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CONCLUSION 
Thus, we showed that GTP interacts with hemoglobin 
and changes the secondary and tertiary structures of 
hemoglobin. Trp residues were exposed to more hydro-
philic environment, which is accompanied with an in-
crease in the β-structure and a decrease in the α-helix 
structure of the protein. So, GTP can affect hemoglobin 
as a ligand to regulate its affinity for oxygen. 
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